The Effects of the L / N‐Type Calcium Channel Blocker (Cilnidipine) on Sympathetic Hyperactive Morning Hypertension: Results From ACHIEVE‐ONE

The Ambulatory Blood Pressure Control and Home Blood Pressure (Morning and Evening) Lowering By N‐Channel Blocker Cilnidipine (ACHIEVE‐ONE) trial is a large‐scale clinical study on blood pressure (BP) and pulse rate (PR) in the real world with use of cilnidipine, a unique L/N‐type Ca channel blocker...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The journal of clinical hypertension (Greenwich, Conn.) Conn.), 2013-02, Vol.15 (2), p.133-142
Hauptverfasser:	Kario, Kazuomi, Ando, Shin‐ichi, Kido, Hidenori, Nariyama, Jin, Takiuchi, Shin, Yagi, Tetsuo, Shimizu, Toshiki, Eguchi, Kazuo, Ohno, Minoru, Kinoshita, Osamu, Yamada, Takahisa
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Blood Pressure - drug effects Blood Pressure - physiology Blood Pressure Monitoring, Ambulatory Calcium Channel Blockers - administration & dosage Calcium Channel Blockers - pharmacology Calcium Channel Blockers - therapeutic use Calcium Channels, L-Type - drug effects Calcium Channels, L-Type - physiology Calcium Channels, N-Type - drug effects Calcium Channels, N-Type - physiology Circadian Rhythm - physiology Dihydropyridines - administration & dosage Dihydropyridines - pharmacology Dihydropyridines - therapeutic use Dose-Response Relationship, Drug Drug Administration Schedule Female Heart Rate - drug effects Heart Rate - physiology Humans Hypertension - drug therapy Hypertension - physiopathology Japan Male Middle Aged Original Paper Original Papers Sympathetic Nervous System - physiology Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!